Still SF [Two-Stage / GS Designs]

posted by VStus – Poland, 2016-10-11 09:10  – Posting: # 16716
Views: 10,246

Hi Helmut,

» lucid words about SF and great ideas about hacking embeded Linux-machines. :-D

Well, it's a proven solution (not by me!), just not quite legal in most of civilized countries ;)

» In a TSD we have some chances to demonstrate BE already in the first stage. Hence, my personal recommendation for n1 75-80% of the fixed sample’s n.

After playing with data from other studies, I've made a suggestion that same recommendation is good single stage cross-over with 2 groups to keep the study safe or "conservative"... We can then demonstrate BE based on larger (first) group if requested by regulators.

Regards, VStus

Complete thread:

 Admin contact
20,144 posts in 4,248 threads, 1,385 registered users;
online 18 (2 registered, 16 guests [including 4 identified bots]).
Forum time (Europe/Vienna): 23:06 CET

Maturity is the capacity to endure uncertainty.    John Finley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz